| William Roman Torreguitart, MD | |
|
746 Ave Hostos, Mayaguez, PR 00682-1538 | |
| (787) 834-8160 | |
| (787) 265-5777 |
| Full Name | William Roman Torreguitart |
|---|---|
| Gender | Male |
| Speciality | Urology |
| Experience | 24 Years |
| Location | 746 Ave Hostos, Mayaguez, Puerto Rico |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1780600072 | NPI | - | NPPES |
| 25265 | Other | PR | MEDICARE PROVIDER |
| CU340A | Other | PR | MEDICARE GROUP |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208800000X | Urology | 14210 (Puerto Rico) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Bella Vista Hospital | Mayaguez, PR | Hospital |
| Entity Name | Roman Urology Group Psc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1285818385 PECOS PAC ID: 0547305633 Enrollment ID: O20100301000220 |
News Archive
Indiana University has been awarded $9.2 million from the National Science Foundation to lead two high-speed international network services. The awards provide IU with $4.6 million to continue the TransPAC3 network connection to Asia, and an additional $4.6 million for a new connection to Europe, named ACE - America Connects to Europe.
Current drugs used to treat heart failure and arrhythmias (irregular heartbeat) have limited effectiveness and have side effects. New basic science findings from a University of Iowa study suggest a way that treatments could potentially be refined so that they work better and target only key heart-related mechanisms.
Intellikine, a leader in the development of small molecule drugs targeting the PI3K/mTOR pathway, and the Multiple Myeloma Research Consortium (MMRC) today announced the initiation of a phase I trial of INK128, a novel, orally-available small molecule kinase inhibitor of the TORC1 and TORC2 complexes, in patients with multiple myeloma.
Perrigo today announced that its licensor and supplier Synthon has received final approval from the U.S. Food and Drug Administration (FDA) for Levocetirizine tablets, a generic version of Xyzal® tablets from UCB/Sepracor, which is marketed in the U.S. by Sanofi-Aventis. Perrigo has the exclusive rights from Synthon to sell and distribute the product in the U.S.
For years cardiologists have threaded hair-like surgical instruments through arteries in the wrist, as an access point to perform procedures on the heart.
› Verified 4 days ago
| Entity Name | Puerto Rico Urology Group Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1356764278 PECOS PAC ID: 7012230519 Enrollment ID: O20150107001911 |
News Archive
Indiana University has been awarded $9.2 million from the National Science Foundation to lead two high-speed international network services. The awards provide IU with $4.6 million to continue the TransPAC3 network connection to Asia, and an additional $4.6 million for a new connection to Europe, named ACE - America Connects to Europe.
Current drugs used to treat heart failure and arrhythmias (irregular heartbeat) have limited effectiveness and have side effects. New basic science findings from a University of Iowa study suggest a way that treatments could potentially be refined so that they work better and target only key heart-related mechanisms.
Intellikine, a leader in the development of small molecule drugs targeting the PI3K/mTOR pathway, and the Multiple Myeloma Research Consortium (MMRC) today announced the initiation of a phase I trial of INK128, a novel, orally-available small molecule kinase inhibitor of the TORC1 and TORC2 complexes, in patients with multiple myeloma.
Perrigo today announced that its licensor and supplier Synthon has received final approval from the U.S. Food and Drug Administration (FDA) for Levocetirizine tablets, a generic version of Xyzal® tablets from UCB/Sepracor, which is marketed in the U.S. by Sanofi-Aventis. Perrigo has the exclusive rights from Synthon to sell and distribute the product in the U.S.
For years cardiologists have threaded hair-like surgical instruments through arteries in the wrist, as an access point to perform procedures on the heart.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| William Roman Torreguitart, MD Po Box 1230, Mayaguez, PR 00681-1230 Ph: (787) 834-8160 | William Roman Torreguitart, MD 746 Ave Hostos, Mayaguez, PR 00682-1538 Ph: (787) 834-8160 |
News Archive
Indiana University has been awarded $9.2 million from the National Science Foundation to lead two high-speed international network services. The awards provide IU with $4.6 million to continue the TransPAC3 network connection to Asia, and an additional $4.6 million for a new connection to Europe, named ACE - America Connects to Europe.
Current drugs used to treat heart failure and arrhythmias (irregular heartbeat) have limited effectiveness and have side effects. New basic science findings from a University of Iowa study suggest a way that treatments could potentially be refined so that they work better and target only key heart-related mechanisms.
Intellikine, a leader in the development of small molecule drugs targeting the PI3K/mTOR pathway, and the Multiple Myeloma Research Consortium (MMRC) today announced the initiation of a phase I trial of INK128, a novel, orally-available small molecule kinase inhibitor of the TORC1 and TORC2 complexes, in patients with multiple myeloma.
Perrigo today announced that its licensor and supplier Synthon has received final approval from the U.S. Food and Drug Administration (FDA) for Levocetirizine tablets, a generic version of Xyzal® tablets from UCB/Sepracor, which is marketed in the U.S. by Sanofi-Aventis. Perrigo has the exclusive rights from Synthon to sell and distribute the product in the U.S.
For years cardiologists have threaded hair-like surgical instruments through arteries in the wrist, as an access point to perform procedures on the heart.
› Verified 4 days ago
Hector M Rodriguez-blazquez, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 14 Calle De Diego E, Medico De Diego 101, Mayaguez, PR 00680 Phone: 787-833-0473 Fax: 787-832-3088 | |
Juan M Colon Rivera, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 410 Ave Hostos, Mayaguez Medical Center, Mayaguez, PR 00682 Phone: 787-806-2020 Fax: 787-832-1257 | |
William R Roman Aqueron, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 746 Ave Hostos, Mayaguez, PR 00682 Phone: 787-834-8160 Fax: 787-265-5777 | |
Benjamin Perez-soto, MD Urology Medicare: Not Enrolled in Medicare Practice Location: Basora 55n, Mayaguez, PR 00080 Phone: 787-832-7378 Fax: 787-805-5440 | |
Dr. Javier E Colon Irizarry, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: Mayaguez Medical Center, 410 Avenida Hostos, Mayaguez, PR 00680 Phone: 787-806-2020 Fax: 787-832-1257 |